Huma Therapeutics Limited

Active07725451 Private limited company
Incorporated
2 August 2011 (15 years)
Previously known as
Humaforhealth Limited (until 17 April 2020)
Medopad Ltd (until 16 April 2020)
This list may be incomplete. See all names on Companies House
Industry
Other telecommunications activities (61900)
Other information technology service activities (62090)
Directors
Eskandar Maleki
Rich Khatib
Controlled by
Danoosh Vahdat
Accounts type
Group
Region
Greater London
Address
13th Floor Millbank Tower
21-24 Millbank
London
SW1P 4QP

Website & contact details

Group website
The site of this company’s group or brand.

Filing status

Accounts due
29 December 2026
Last accounts
31 December 2024
Conf. stmt due
9 December 2026
Last conf. stmt
25 November 2025

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 3 active

Officer details are public data from the Companies House register.

Maleki, Eskandar
Director · Appointed 7 March 2018
Austrian
Born December 1950 (75)
Khatib, Rich, Dr
Director · Appointed 1 August 2012
British
Born December 1964 (61)
Director · Appointed 1 August 2012
British
Born August 1984 (42)
Officer history (6 former)
17 October 2023
Resigned Suessmuth-Dyckerhoff, Claudia Ricarda Rita, Dr as Director
17 October 2023
Resigned Fletcher, Stuart Robert as Director
17 October 2023
Resigned Milburn, Alan as Director
1 April 2021
Appointed Suessmuth-Dyckerhoff, Claudia Ricarda Rita, Dr as Director
23 September 2020
Resigned Mackinnon, Simon John as Director
8 April 2020
Appointed Milburn, Alan as Director
7 March 2018
Appointed Maleki, Eskandar as Director
27 December 2017
Appointed Fletcher, Stuart Robert as Director
25 October 2017
Appointed Mackinnon, Simon John as Director
1 August 2012
Appointed Vahdat, Danoosh as Director
1 August 2012
Appointed Khatib, Rich, Dr as Director
1 August 2012
Resigned Oxley, Mark as Director
1 August 2012
Resigned @Ukplc Client Director Ltd as Corporate Director
2 August 2011
Appointed Oxley, Mark as Director
2 August 2011
Appointed @Ukplc Client Director Ltd as Corporate Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Individual · Notified 9 April 2020
Right to appoint and remove directors
British
Born August 1984 (42)
Former controllers (2)
17 January 2019
Ceased Danoosh Vahdat — Owns 25–50% of shares
17 January 2019
Ceased Rich Khatib — Owns 25–50% of shares

Group structure 4 companies

Ownership group derived from the Companies House PSC register

Huma Therapeutics Limited This company
Econsult Health Limited Owns 75–100% of shares
Iplato Limited Owns 75–100% of shares
Iplato Healthcare Limited Owns 75–100% of shares

Financials

Balance sheet as at 31 December 2024 · group accounts

Cash
£7,765,000
Profit
(£18,400,000)
Current Ratio
5.4x

Trend

Cash
£0 £20.0M £40.0M £60.0M 2019 2020 2021 2024 £10,828,000 £5,248,000 £44,407,000 £7,765,000
Balance sheet detail
20242022202120202019
Fixed Assets£56,940,000£15,278,000£2,605,000£755,000
Current Assets£57,503,000£68,167,000£66,216,000£24,883,000£25,733,000
Debtors£40,387,000£10,288,000£9,716,000£4,872,000
Cash£7,765,000£44,407,000£5,248,000£10,828,000
Creditors (< 1 year)£10,737,000£5,247,000£6,204,000£2,180,000
Net Current Assets£46,766,000£60,969,000£18,679,000£23,553,000
Shareholder Funds£77,395,000£76,247,000£21,284,000£24,308,000

Filings

Recent filings only. See the full history on Companies House

Show all recent filings

Other companies in this industry

By trade and location

New companies in London →

Explore the largest companies

Largest companies in London, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?